Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.700
+0.010 (0.59%)
Jul 20, 2026, 3:29 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 194.81 million as of July 20, 2026. Its market cap has increased by 46.40% in one year.
Market Cap
194.81M
Enterprise Value
167.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.70
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 194.81M, an increase of 106.55%. That is a compound annual growth rate of 10.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 194.81M | 49.44% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cresco Labs | 388.33M |
| Auxly Cannabis Group | 258.04M |
| TerrAscend | 235.27M |
| Aurora Cannabis | 229.19M |
| Cannara Biotech | 189.66M |
| Organigram Global | 175.97M |
| BioSyent | 165.86M |
| Medexus Pharmaceuticals | 160.84M |